-
Kenya's economy faces climate change risks: World Bank
-
Nasdaq rallies again while yen falls despite BOJ rate hike
-
US university killer's mystery motive sought after suicide
-
IMF approves $206 mn aid to Sri Lanka after Cyclone Ditwah
-
Rome to charge visitors for access to Trevi Fountain
-
Stocks advance with focus on central banks, tech
-
Norway crown princess likely to undergo lung transplant
-
France's budget hits snag in setback for embattled PM
-
Volatile Oracle shares a proxy for Wall Street's AI jitters
-
Japan hikes interest rates to 30-year-high
-
Brazil's top court strikes down law blocking Indigenous land claims
-
'We are ghosts': Britain's migrant night workers
-
Asian markets rise as US inflation eases, Micron soothes tech fears
-
Trump signs $900 bn defense policy bill into law
-
EU-Mercosur deal delayed as farmers stage Brussels show of force
-
Harrison Ford to get lifetime acting award
-
Trump health chief seeks to bar trans youth from gender-affirming care
-
Argentine unions in the street over Milei labor reforms
-
Brazil open to EU-Mercosur deal delay as farmers protest in Brussels
-
Brussels farmer protest turns ugly as EU-Mercosur deal teeters
-
US accuses S. Africa of harassing US officials working with Afrikaners
-
ECB holds rates as Lagarde stresses heightened uncertainty
-
Trump Media announces merger with fusion power company
-
Stocks rise as US inflation cools, tech stocks bounce
-
Zelensky presses EU to tap Russian assets at crunch summit
-
Danish 'ghetto' residents upbeat after EU court ruling
-
ECB holds rates but debate swirls over future
-
Bank of England cuts interest rate after UK inflation slides
-
Have Iran's authorities given up on the mandatory hijab?
-
British energy giant BP extends shakeup with new CEO pick
-
EU kicks off crunch summit on Russian asset plan for Ukraine
-
Sri Lanka plans $1.6 bn in cyclone recovery spending in 2026
-
Most Asian markets track Wall St lower as AI fears mount
-
Danish 'ghetto' tenants hope for EU discrimination win
-
What to know about the EU-Mercosur deal
-
Trump vows economic boom, blames Biden in address to nation
-
ECB set to hold rates but debate swirls over future
-
EU holds crunch summit on Russian asset plan for Ukraine
-
Nasdaq tumbles on renewed angst over AI building boom
-
Billionaire Trump nominee confirmed to lead NASA amid Moon race
-
CNN's future unclear as Trump applies pressure
-
German MPs approve 50 bn euros in military purchases
-
EU's Mercosur trade deal hits French, Italian roadblock
-
Warner Bros rejects Paramount bid, sticks with Netflix
-
Crude prices surge after Trump orders Venezuela oil blockade
-
Warner Bros. Discovery rejects Paramount bid
-
Doctors in England go on strike for 14th time
-
Ghana's Highlife finds its rhythm on UNESCO world stage
-
Stocks gain as traders bet on interest rate moves
-
France probes 'foreign interference' after malware found on ferry
Human brain cells implanted in rats offer research gold mine
Scientists have successfully implanted and integrated human brain cells into newborn rats, creating a new way to study complex psychiatric disorders such as schizophrenia and autism, and perhaps eventually test treatments.
Studying how these conditions develop is incredibly difficult -- animals do not experience them like people, and humans cannot simply be opened up for research.
Scientists can assemble small sections of human brain tissue derived from stem cells in petri dishes, and have already done so with more than a dozen brain regions.
But in dishes, "neurons don't grow to the size which a human neuron in an actual human brain would grow", said Sergiu Pasca, the study's lead author and professor of psychiatry and behavioural sciences at Stanford University.
And isolated from a body, they cannot tell us what symptoms a defect will cause.
To overcome those limitations, researchers implanted the groupings of human brain cells, called organoids, into the brains of young rats.
The rats' age was important: human neurons have been implanted into adult rats before, but an animal's brain stops developing at a certain age, limiting how well implanted cells can integrate.
"By transplanting them at these early stages, we found that these organoids can grow relatively large, they become vascularised (receive nutrients) by the rat, and they can cover about a third of a rat's (brain) hemisphere," Pasca said.
- Ethical dilemmas -
To test how well the human neurons integrated with the rat brains and bodies, air was puffed across the animals' whiskers, which prompted electrical activity in the human neurons.
That showed an input connection -- external stimulation of the rat's body was processed by the human tissue in the brain.
The scientists then tested the reverse: could the human neurons send signals back to the rat's body?
They implanted human brain cells altered to respond to blue light, and then trained the rats to expect a "reward" of water from a spout when blue light shone on the neurons via a cable in the animals' skulls.
After two weeks, pulsing the blue light sent the rats scrambling to the spout, according to the research published Wednesday in the journal Nature.
The team has now used the technique to show that organoids developed from patients with Timothy syndrome grow more slowly and display less electrical activity than those from healthy people.
The technique could eventually be used to test new drugs, according to J. Gray Camp of the Roche Institute for Translational Bioengineering, and Barbara Treutlein of ETH Zurich.
It "takes our ability to study human brain development, evolution and disease into uncharted territory", the pair, who were not involved in the study, wrote in a review commissioned by Nature.
The method raises potentially uncomfortable questions -- how much human brain tissue can be implanted into a rat before the animal's nature is changed? Would the method be ethical in primates?
Pasca argued that limitations on how deeply human neurons integrate with the rat brain provide "natural barriers".
Rat brains develop much faster than human ones, "so there's only so much that the rat cortex can integrate".
But in species closer to humans, those barriers might no longer exist, and Pasca said he would not support using the technique in primates for now.
He argued though that there is a "moral imperative" to find ways to better study and treat psychiatric disorders.
"Certainly the more human these models are becoming, the more uncomfortable we feel," he said.
But "human psychiatric disorders are to a large extent uniquely human. So we're going to have to think very carefully... how far we want to go with some of these models moving forward."
P.Kolisnyk--CPN